Shares of Anavex Life Sciences AVXL, a clinical-stage biotech making medicines to treat central nervous system (CNS) diseases, have skyrocketed 94.7% in the past three months due to recent ...
Shares of Anavex Life Sciences AVXL, a clinical-stage biotech making medicines to treat central nervous system (CNS) diseases, have skyrocketed 94.7% in the past three months due to recent pipeline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback